摘要 |
A pharmaceutical composition useful as a preventive or therapeutic agent for immune-related diseases. The pharmaceutical composition includes at least HMG-COA reductase inhibitor and at least one amino alcohol compound having the following formula (I), a pharmacologically acceptable salt thereof, or a pharmacologically acceptable ester thereof wherein R<SUP>1 </SUP>and R<SUP>2 </SUP>each represents hydrogen; R<SUP>3 </SUP>represents lower alkyl or hydroxymethyl; R<SUP>4 </SUP>represents hydrogen, alkyl, alkoxy or halogen; R<SUP>5 </SUP>represents hydrogen, halogeno, cyclohexyl or phenyl; X represents vinylene (CH-CH), oxygen, sulfur or methylated nitrogen; Y represents a single bond, oxygen, sulfur or carbonyl; Z represents a single bond or C<SUB>1</SUB>-C<SUB>8 </SUB>alkylene; n is 2 or 3.
|